Recently, Li et al. explored the mechanisms of lipid metabolic reprogramming in breast cancer BM and identified that the retinoic acid receptor responder 2 (RARRES2) gene was significantly downregulated and was associated with enhanced lipid synthesis and fatty acid metabolism signatures [29]. The gene discussed is RARRES2; the disease is breast cancer.